Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - gliclazide, quantity: 30 mg - tablet, modified release - excipient ingredients: stearic acid; hypromellose; colloidal anhydrous silica - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose. during controlled clinical trials in patients with type ii diabetes, gliclazide mr 30 mg tablets, taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - gliclazide - modified-release tablets - 30 milligram - sulfonylureas

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - gliclazide - modified-release tablets - 30 milligram

Birleşik Krallık - İngilizce - myHealthbox

mercury pharmaceuticals limited - gliclazide - modified-release tablet - 30mg - sulphonamides, urea derivative - it is indicated in adults for treatment of non-insulin dependent diabetes (type 2) when dietary measures, physical exercise and weight loss alone are not sufficient to control blood glucose.

Birleşik Krallık - İngilizce - myHealthbox

mercury pharmaceuticals limited - gliclazide - modified-release tablet - 60mg - sulphonamides, urea derivative - it is indicated in adults for treatment of non-insulin dependent diabetes (type 2) when dietary measures, physical exercise and weight loss alone are not sufficient to control blood glucose.

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

les laboratoires servier - gliclazide - modified-release tablets - 60 milligram

Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - gliclazide - modified-release tablet - 30mg

Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - gliclazide - modified-release tablet - 60mg

Filipinler - İngilizce - FDA (Food And Drug Administration)

n/a; importer: ambica international corporation; distributor: tgp pharma inc. - gliclazide - modified release tablet - 60 mg modified release tablet

Malta - İngilizce - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - gliclazide - modified-release tablet - gliclazide 30 mg - drugs used in diabetes